Find Information About:

Drugs & Supplements

Get information and reviews on prescription drugs, over-the-counter medications, vitamins, and supplements. Search by name or medical condition.

Pill Identifier

Pill Identifier

Having trouble identifying your pills?

Enter the shape, color, or imprint of your prescription or OTC drug. Our pill identification tool will display pictures that you can compare to your pill.

Get Started

My Medicine

Save your medicine, check interactions, sign up for FDA alerts, create family profiles and more.

Get Started

WebMD Health Experts and Community

Talk to health experts and other people like you in WebMD's Communities. It's a safe forum where you can create or participate in support groups and discussions about health topics that interest you.

  • Second Opinion

    Second Opinion

    Read expert perspectives on popular health topics.

  • Community


    Connect with people like you, and get expert guidance on living a healthy life.

Got a health question? Get answers provided by leading organizations, doctors, and experts.

Get Answers

Sign up to receive WebMD's award-winning content delivered to your inbox.

Sign Up

Parkinson's Disease Health Center

Font Size

Nicotine Slows Parkinson's Disease

Study in Monkeys Suggests the Drug May Help if Given Early
WebMD Health News
Reviewed by Louise Chang, MD

Aug. 11, 2006 -- Nicotine protects brain cells most affected by Parkinson's diseaseParkinson's disease, studies in monkeys show.

The findings, by Maryka Quik, PhD, and colleagues at The Parkinson's Institute in California, indicate nicotine might slow Parkinson's if given very early in the disease process.

They also help explain why cigarette smokers get Parkinson's disease less often than nonsmokers.

Parkinson's disease occurs when brain cells that produce dopamine -- an important chemical messenger -- die off.

Nicotine may protect these cells from toxic damage.

In their study, Quik and colleagues spiked squirrel monkeys' drinking water with nicotine so the animals' blood levels of the drug were similar to that in human smokers.

After six months on nicotine, the researchers gave the monkeys a toxin that kills the dopamine-producing cells and mimics the effects of Parkinson's.

The toxin did 25% less cell damage to the brains of the nicotine-treated monkeys.

Quik and colleagues note that people don't get Parkinson's symptoms until 80% to 90% of their dopamine-producing cells are dead.

"This means that a reduction in [brain cell] damage from 80% to 60% can mean the difference between having disease symptoms and being symptom-free," Quik says, in a news release.

People worried about Parkinson's disease should not all start smoking, warns David A. Schwartz, MD, director of the National Institute of Environmental Health Sciences, the agency that funded the Quik study.

"While we would never recommend that people smoke, these results suggest that nicotine promotes the survival of dopamine-producing cells in animals with no overt Parkinson's symptoms," Schwartz says, in a news release. "These findings have implications for its use in slowing the progression of Parkinson's."

It's not clear how nicotine protects these crucial brain cells. Quik and colleagues suggest the drug may stimulate release of brain chemicals that help nerve cells grow and recover from injury.

The study appears in the early online edition of the Journal of Neurochemistry.

Today on WebMD

Parkinsons disease illustration
Causes, symptoms, and treatments.
hands on walker
How does the disease progress?
man with serious expression
8 common questions and answers.
intelligence quotient illustration
What are the advantages of DBS?
Parkinsons Disease Medications
Questions Doctor Parkinsons
Eating Right
Parkinsons Exercise
daughter consoling depressed mother
senior man's hands
Parkinsons Daily